Immunocore Holdings plc (IMCR) Insider Trading
Over the last 6 months, 103 institutions increased and 89 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Mar
Sep
Oct
Nov
Dec
Feb
Context3-month price +28.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | Ratcliffe Peter Johndirector | Grant | 27,492 | $28.52 |
| May 28, 2026 | Peterson Kristinedirector | Grant | 27,492 | $28.52 |
| May 28, 2026 | Pao Williamdirector | Grant | 27,492 | $28.52 |
| May 28, 2026 | Kaul Siddharthdirector | Grant | 27,492 | $28.52 |
| May 28, 2026 | Bell John Irvingdirector | Grant | 27,492 | $28.52 |
| May 28, 2026 | Herbst Roy Stevendirector | Grant | 27,492 | $28.52 |
| Feb 19, 2026 | Coy Travis Alanofficer: Chief Financial Officer | Grant | 95,637 | $32.38 |
| Feb 19, 2026 | Coy Travis Alanofficer: Chief Financial Officer | Grant | 33,353 | — |
| Feb 19, 2026 | Jallal Bahijadirector, officer: CHIEF EXECUTIVE OFFICER | Option | 23,817 | — |
| Feb 19, 2026 | Jallal Bahijadirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 11,474 | $32.35 |
| Feb 19, 2026 | St Leger Tina Amberofficer: CHIEF HR OFFICER | Option | 2,119 | — |
| Feb 19, 2026 | GOLL JOHNofficer: SVP, FINANCE & CAO | Grant | 7,411 | — |
| Feb 19, 2026 | GOLL JOHNofficer: SVP, FINANCE & CAO | Sell | 698 | $32.35 |
| Feb 19, 2026 | GOLL JOHNofficer: SVP, FINANCE & CAO | Option | 1,351 | — |
| Feb 19, 2026 | Jallal Bahijadirector, officer: CHIEF EXECUTIVE OFFICER | Grant | 88,573 | — |
| Feb 19, 2026 | Jallal Bahijadirector, officer: CHIEF EXECUTIVE OFFICER | Grant | 395,066 | $32.38 |
| Feb 19, 2026 | Berman David Mofficer: HEAD OF R&D | Sell | 5,965 | $32.35 |
| Feb 19, 2026 | Berman David Mofficer: HEAD OF R&D | Option | 11,824 | — |
| Feb 19, 2026 | St Leger Tina Amberofficer: CHIEF HR OFFICER | Sell | 1,000 | $32.35 |
| Feb 19, 2026 | GOLL JOHNofficer: SVP, FINANCE & CAO | Grant | 21,252 | $32.38 |
| Dec 8, 2025 | Berman David Mofficer: HEAD OF R&D | Sell | 572 | $40.14 |
| Dec 8, 2025 | Berman David Mofficer: HEAD OF R&D | Sell | 31,341 | $40.26 |
| Dec 8, 2025 | Berman David Mofficer: HEAD OF R&D | Option | 572 | $17.46 |
| Dec 8, 2025 | Berman David Mofficer: HEAD OF R&D | Option | 31,341 | $17.46 |
| Dec 1, 2025 | Berman David Mofficer: HEAD OF R&D | Option | 5,521 | $17.46 |
| Dec 1, 2025 | Berman David Mofficer: HEAD OF R&D | Option | 69,404 | $17.46 |
| Dec 1, 2025 | Berman David Mofficer: HEAD OF R&D | Sell | 5,521 | $40.09 |
| Dec 1, 2025 | Berman David Mofficer: HEAD OF R&D | Sell | 69,404 | $40.12 |
| Nov 26, 2025 | Berman David Mofficer: HEAD OF R&D | Sell | 18,020 | $40.03 |
| Nov 26, 2025 | Berman David Mofficer: HEAD OF R&D | Sell | 100 | $40.00 |
Source: IMCR SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their IMCR positions over the last 6 months (SEC Form 13F).
Increased
103
New positions
49
Reduced
89
Sold out
33
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 5.7M | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 4.9M | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 4.9M | Aug 14, 2026 |
| FMR LLC | Increased | 4.8M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4.7M | May 15, 2026 |
| FMR LLC | Reduced | 4.3M | Aug 13, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 3.7M | May 11, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 3.6M | Aug 14, 2026 |
| BELLEVUE GROUP AG | Unchanged | 2.8M | May 15, 2026 |
| Bellevue Group AG | Reduced | 2.8M | Aug 14, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 2.8M | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 2.6M | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 2.6M | Aug 14, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 1.9M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 1.9M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.